LEADER 04729nam 2201525z- 450 001 9910346843303321 005 20231214132957.0 010 $a3-03897-066-2 035 $a(CKB)4920000000095207 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/58295 035 $a(EXLCZ)994920000000095207 100 $a20202102d2019 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aResearch of Pathogenesis and Novel Therapeutics in Arthritis 210 $cMDPI - Multidisciplinary Digital Publishing Institute$d2019 215 $a1 electronic resource (366 p.) 311 $a3-03897-065-4 330 $aArthritis has a high prevalence globally and includes over 100 different types, the most common of which are rheumatoid arthritis, osteoarthritis, psoriatic arthritis, and inflammatory arthritis. The exact etiology of arthritis remains unclear and no cure exists. Anti-inflammatory drugs are commonly used in the treatment of arthritis but are associated with significant side effects. Novel modes of therapy and additional prognostic biomarkers are urgently needed for arthritis patients. This book summarizes and discusses the global picture of the current understanding of arthritis. 610 $areceptor activator of nuclear factor ?B 610 $ainfliximab 610 $atripterine 610 $atriptolide 610 $aosteoblast 610 $atumor necrosis factor-alpha 610 $asynovial cell 610 $aanti-arthritis 610 $abiosimilars 610 $aEpstein-Barr virus 610 $acytokines 610 $aSOX9 610 $aparathyroid hormone 610 $anitric oxide 610 $arat 610 $aetanercept 610 $aangiogenesis 610 $aglycosylation 610 $amitogen activated protein kinase 610 $aTh9 lymphocytes 610 $arheumatoid arthritis 610 $aIL-6 610 $aclodronate 610 $abone erosion 610 $amesenchymal stem cells 610 $acollagen-induced arthritis 610 $abiological 610 $agene expression 610 $ainflammatory arthritis 610 $aosteoarthritis 610 $afraxinellone 610 $anuclear factor kappa B 610 $amessenger RNA 610 $ainflammation 610 $amiRNA 610 $adisease-modifying 610 $aadipokines 610 $aWNT 610 $aglycoprotein 42 610 $amiR-199a-5p 610 $aproliferation 610 $anext-generation sequencing 610 $acollagen 610 $aosteoarthritis (OA) 610 $aexperimental arthritis 610 $abone morphogenetic protein 610 $aTNF-? 610 $acomputational modeling 610 $abasic research 610 $aosteoclast 610 $atherapeutics 610 $acertolizumab pegol 610 $achondrocytes 610 $aprogenitor cells 610 $aadjuvant arthritis 610 $aadalimumab 610 $atriterpenoid 610 $asclareol 610 $aTNF? 610 $afibroblast growth factor 2 610 $aantibodies 610 $aosteoblasts 610 $amolecular pathology 610 $aTh17 610 $aimmunology 610 $aobesity 610 $avisfatin 610 $aarticular cartilage 610 $aautoimmune 610 $abiomarkers 610 $acelastrol 610 $aMAPK 610 $adisease pathways 610 $aIL1? 610 $aarthritis 610 $abioinformatics 610 $aanticitrullinated peptide antibodies 610 $adrug delivery system 610 $aantagonists 610 $ashared epitope 610 $apathology 610 $aSMA- and MAD-related protein 610 $asmall-molecule inhibitor 610 $atransforming growth factor ? 610 $amice 610 $agolimumab 610 $aspinal fusion 610 $aantirheumatic drug 610 $aearly osteoarthritis 610 $astem cell 610 $arheumatoid factor 610 $atherapeutic antibody 610 $abisphosphonate 610 $aosteoclastogenesis 610 $ainterleukin 610 $aspondyloarthropathies 610 $aclinical translation 610 $atherapy 610 $aTraditional Chinese medicine 610 $achemokines 610 $astructure 610 $acell signaling 610 $amicroRNA 700 $aTang$b Chih-Hsin$4auth$01305960 906 $aBOOK 912 $a9910346843303321 996 $aResearch of Pathogenesis and Novel Therapeutics in Arthritis$93028066 997 $aUNINA